Opioids – Medical Alley Association


Pear Therapeutics Announces First Participant Enrolled in National Institutes of Health Clinical Trial Investigating Combinations of Pharmacological and Behavioral Interventions to Treat Opioid Use Disorder

Boston and San Francisco – Pear Therapeutics, Inc. today announced the first participant enrolled in the National Institute on Drug Abuse (NIDA) Clinical Trials Network (CTN)-0100 study on optimizing retention, duration, and discontinuation strategies for pharmacotherapy treatment of opioid use disorder (OUD), using Pear’s prescription digital therapeutic (PDT) reSET-O®.  Investigators will study reSET-O, in conjunction with high- and standard-dose transmucosal […]

At The Table – April 23, 2019

Minnesota Legislature Begins Passing Budget Bills; Update on Medical Alley Association 2019 State Legislative Agenda Following their “spring break,” legislators are gearing up for a critical stretch of this session: ten days of budget bills. Starting today, the House and Senate will begin consideration of their respective omnibus finance bills. Each of these bills funds […]

At The Table – January 28, 2019

Congressman Phillips Tours Two Medical Alley Association Members On Tuesday morning, January 22, Medial Alley Association had the pleasure of joining Congressman Dean Philips from Minnesota’s 3rd congressional district and Mayor Jeff Lunde of Brooklyn Park to tour Medical Alley companies. The morning started off at Olympus Surgical Technologies America. Medical Alley Association was able […]

April 24, 2018: Capitol News

Last week at the Capitol Last week saw a flurry of activity at the Minnesota Capitol. Supplemental budget bills for all finance committees in the House and Senate were put forward and passed. Medical Alley Association is closely tracking all of the bills; however, five (three in the House, two in the Senate) are of […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER